By
Daily Mail City Finance
|
A pharmaceutical company that specialises in developing drugs by putting together existing treatments is to float on the Alternative Investment Market.
Fast Track Pharma is seeking to raise £2million, which will allow it to increase the number of products it develops. The listing will give it a market value of £10million.
The firm, which focuses on sexual health and has developed a treatment for erectile dysfunction, says the time taken to test new drugs is greatly reduced by using others that already have licences.
Sexual health focus: Fast Track has developed a treatment for erectile dysfunction
Executive chairman Dr Steven Powell said: ‘The funds raised will help to support . . . future opportunities.’
Comments (0)
Share what you think
No comments have so far been submitted. Why not be the first to send us your thoughts,
or debate this issue live on our message boards.
Who is this week’s top commenter?
Find out now
Fast Track Pharma seeking to raise £2m in AIM float
No comments:
Post a Comment